Prescribing Information Important Safety Information Patient Site Request a Rep Teva Logo
Selarsdi (ustekinumab-aekn) injection logo
  • About SELARSDI
  • Clinical Evidence
    Overview Pharmacokinetics study Biosimilarity study
  • Administration & Dosing
  • Savings Program
  • Resources
  • About SELARSDI
  • Clinical Evidence
    Overview Pharmacokinetics study Biosimilarity study
  • Administration & Dosing
  • Savings Program
  • Resources

Site map

HOME PAGE
ABOUT SELARSDI
CLINICAL EVIDENCE Overview Pharmacokinetics study Biosimilarity study
ADMINISTRATION & DOSING
SAVINGS PROGRAM
RESOURCES

Are you a US healthcare professional?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?

 

SELARSDI® coverage
is expanding

As of January 1, 2026,
SELARSDI is now preferred on:

  • Express Scripts (National Preferred Formulary, Basic, High Performance & Flex)
  • Cigna
  • Texas Medicaid
  • Anthem Blue Cross Blue Shield of California
  • Blue Cross Blue Shield of Florida
  • Anthem Blue Cross Blue Shield of Indiana
  • Anthem Blue Cross Blue Shield of Ohio
  • Anthem Blue Cross Blue Shield of Virginia
  • Blue Cross Blue Shield of Alabama
  • Blue Cross Blue Shield of Minnesota
  • Blue Cross Blue Shield of Kansas
  • Blue Cross Blue Shield of North Dakota
  • Express Scripts MPD
  • Capital Health Plan

This is not a complete list. Coverage varies by insurer. Check your patient's health plan.

UST-40215 August 2026

Legal Notice Privacy Notice Consumer Health Privacy Policy Privacy Choices icon Your Privacy Choices Site Map

Stelara® is a registered trademark of
Johnson & Johnson and its affiliates.

© 2026 Teva Pharmaceuticals, Inc.

UST-40205  August 2026

Small United States flag This site is intended for US Healthcare Professionals only.

Teva Biosimilars logo